scholarly journals Anticandidal activity of medicinal plants and Pseudomonas aeruginosa strains of clinical specimens

2016 ◽  
Vol 49 (2) ◽  
pp. 276-280 ◽  
Author(s):  
Limpon Bora
Mycoses ◽  
2007 ◽  
Vol 50 (1) ◽  
pp. 74-78 ◽  
Author(s):  
Ilknur Kaleli ◽  
Nural Cevahir ◽  
Melek Demir ◽  
Umut Yildirim ◽  
Rasim Sahin

2016 ◽  
Vol 4 (2) ◽  
pp. 112 ◽  
Author(s):  
Alok K Mishra ◽  
Rikesh K Dubey ◽  
Shivraj M Yabaji ◽  
Swati Jaiswal

Rhamnolipids (RLs) are the bacterial derived biosurfactants and known for a wide range of industrial and therapeutic applications. They exhibit potent anti-bacterial activity against various gram positive, gram negative and acid fast bacteria including Mycobacterium tuberculosis. Since, Pseudomonas is one of the largest known genuses containing a variety of rhamnolipid producing strains. Therefore, in this study, we selectively isolated the Pseudomonas aeruginosa strains from the rhizospheric soil of the Indian plants of medicinal value, e.g. Azadirachta Indica and Ficus spp., and evaluated them for their natural ability to produce antibacterial rhamnolipids. The bacteria were identified on the basis of 16s rRNA sequencing and biochemical characterization. Among 33 of P. aeruginosa isolates from different soil samples, four isolates showed potent inhibitory activity against methicillin resistant Staphylococcus aureus (MRSA) and fast grower mycobacterial spp. The inhibitory potential of the isolates was found to be correlated with their ability to produce RLs in the medium. The industrial viability of the strains was assessed on the basis of cytotoxicity determining alternative allele, exoS/exoU and cell mediated cytotoxicity against murine macrophages J774.1. The newly isolated strains harbor exoS allele and exhibits lower cell mediated cytotoxicity on macrophage cell line as compared to the clinical strains PA-BAA-427 and PA-27853 used as a control in this study.Evaluation of antimycobacterial rhamnolipid production from non-cytotoxic strains of Pseudomonas aeruginosa isolated from rhizospheric soil of medicinal plants


2021 ◽  
Vol 16 (1) ◽  
pp. 1-8
Author(s):  
Hosniyeh E. Ladadweh ◽  
Hiba H. Falana ◽  
Jannat M. Ma�ali ◽  
Pinar A. Aweis ◽  
Hanan N. Nofal ◽  
...  

2021 ◽  
Vol 14 (8) ◽  
Author(s):  
Seyed Ali Bazghandi ◽  
Mohsen Arzanlou ◽  
Hadi Peeridogaheh ◽  
Hamid Vaez ◽  
Amirhossein Sahebkar ◽  
...  

Background: Drug resistance and virulence genes are two key factors for the colonization of Pseudomonas aeruginosa in settings with high antibiotic pressure, such as hospitals, and the development of hospital-acquired infections. Objectives: The objective of this study was to investigate the prevalence of drug resistance and virulence gene profiles in clinical isolates of P. aeruginosa in Ardabil, Iran. Methods: A total of 84 P. aeruginosa isolates were collected from clinical specimens of Ardabil hospitals and confirmed using laboratory standard tests. The disk diffusion method was used for antibiotic susceptibility testing and polymerase chain reaction (PCR) for the identification of P. aeruginosa virulence genes. Results: The highest and the lowest antibiotic resistance rates of P. aeruginosa strains were against ticarcillin-clavulanate (94%) and doripenem (33.3%), respectively. In addition, the frequency of multidrug-resistant (MDR) P. aeruginosa was 55.9%. The prevalence of virulence factor genes was as follows: algD 84.5%, lasB 86.9%, plcH 86.9%, plcN 86.9%, exoU 56%, exoS 51.2%, toxA 81%, nan1 13.1%, and pilB 33.3%. A significant association was observed between resistance to some antibiotics and the prevalence of virulence genes in P. aeruginosa. Conclusions: Our results revealed a high prevalence of antibiotic resistance, especially MDR, and virulence-associated genes in clinical isolates of P. aeruginosa in Ardabil hospitals. Owing to the low resistance rates against doripenem, gentamicin, and tobramycin, these antibiotics are recommended for the treatment of infections caused by highly resistant and virulent P. aeruginosa strains.


1982 ◽  
Vol 16 (3) ◽  
pp. 458-463 ◽  
Author(s):  
N J Legakis ◽  
M Aliferopoulou ◽  
J Papavassiliou ◽  
M Papapetropoulou

2020 ◽  
Vol Volume 13 ◽  
pp. 2261-2275
Author(s):  
Hajar Mohammadi Barzelighi ◽  
Bita Bakhshi ◽  
Bahram Daraei ◽  
Hossein Fazeli ◽  
Bahram Nasr Esfahani

Sign in / Sign up

Export Citation Format

Share Document